Your browser is no longer supported. Please, upgrade your browser.
Settings
ABT Abbott Laboratories daily Stock Chart
ABT [NYSE]
Abbott Laboratories
IndexS&P 500 P/E53.81 EPS (ttm)0.90 Insider Own0.70% Shs Outstand1.73B Perf Week-0.19%
Market Cap83.74B Forward P/E17.59 EPS next Y2.76 Insider Trans-3.17% Shs Float1.72B Perf Month7.73%
Income1.39B PEG4.80 EPS next Q0.61 Inst Own73.60% Short Float0.99% Perf Quarter8.53%
Sales22.30B P/S3.75 EPS this Y-58.60% Inst Trans13.63% Short Ratio2.51 Perf Half Y25.60%
Book/sh18.16 P/B2.67 EPS next Y11.67% ROA3.00% Target Price48.96 Perf Year29.07%
Cash/sh5.13 P/C9.45 EPS next 5Y11.22% ROE6.40% 52W Range37.38 - 49.59 Perf YTD26.22%
Dividend1.06 P/FCF75.72 EPS past 5Y0.00% ROI6.70% 52W High-1.37% Beta1.58
Dividend %2.19% Quick Ratio2.30 Sales past 5Y-0.50% Gross Margin55.50% 52W Low30.85% ATR0.64
Employees75000 Current Ratio2.90 Sales Q/Q29.70% Oper. Margin11.00% RSI (14)70.24 Volatility1.31% 1.32%
OptionableYes Debt/Eq0.76 EPS Q/Q489.40% Profit Margin6.70% Rel Volume1.04 Prev Close48.48
ShortableYes LT Debt/Eq0.76 EarningsJul 19 BMO Payout107.00% Avg Volume6.78M Price48.91
Recom2.00 SMA202.39% SMA507.52% SMA20014.85% Volume2,535,847 Change0.89%
Jun-29-17Resumed Jefferies Buy
Jun-29-17Initiated Guggenheim Buy $58
Jun-21-17Resumed BTIG Research Buy $56
May-16-17Initiated Goldman Neutral $45
Apr-20-17Reiterated Barclays Overweight $50 → $52
Mar-01-17Reiterated RBC Capital Mkts Outperform $46 → $50
Jan-26-17Reiterated RBC Capital Mkts Outperform $48 → $46
Jul-21-16Reiterated Barclays Overweight $48 → $50
Jun-21-16Upgrade Edward Jones Hold → Buy
Apr-11-16Reiterated RBC Capital Mkts Outperform $45 → $48
Jan-04-16Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-07-15Upgrade Jefferies Hold → Buy
Nov-13-15Downgrade Goldman Buy → Neutral
Oct-09-15Reiterated RBC Capital Mkts Outperform $55 → $51
Oct-07-15Upgrade Barclays Equal Weight → Overweight $55 → $52
Jul-23-15Reiterated Stifel Buy $53 → $58
Jul-23-15Reiterated RBC Capital Mkts Outperform $51 → $55
Jul-23-15Reiterated Barclays Equal Weight $53 → $55
Apr-23-15Reiterated Stifel Buy $52 → $53
Mar-27-15Reiterated Barclays Equal Weight $48 → $52
Jun-29-17 10:20AM  Anadarko, Abbott Labs Are Buys Before They Soar Double Digits -- Analysts TheStreet.com
Jun-28-17 04:05PM  Could Philips' Rivals Stage A Coup For Spectranetics? Investor's Business Daily
Jun-27-17 08:38AM  The Forgotten $35 Billion U.S. Healthcare Problem Forbes
Jun-26-17 03:12PM  ETFs with exposure to Abbott Laboratories : June 26, 2017 Capital Cube
Jun-23-17 01:32PM  Top Stock Reports for Oracle, Allergan & Abbott Zacks
11:00AM  Why This Healthcare ETF Is Surging Investopedia
Jun-21-17 09:00AM  Abbott Hosts Conference Call for Second-Quarter Earnings PR Newswire
Jun-20-17 05:37PM  How to Uncover Institutional Buying Zacks
Jun-19-17 11:51AM  Abbott Laboratories :ABT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 19, 2017 Capital Cube
09:08AM  How Strykers Margins Are Driven by Its CTG Program Market Realist
Jun-16-17 02:35PM  2 Solid Medical Device Stocks to Scoop Up Right Away Zacks
Jun-15-17 12:52PM  ETFs with exposure to Abbott Laboratories : June 15, 2017 Capital Cube
09:30AM  The Zacks Analyst Blog Highlights: United Technologies, Abbott, Delta Air, Equity Residential and Ross Stores Zacks
09:26AM  Abbott Laboratories Up on EPD & Buyouts, Pediatric Weak Zacks
06:00AM  Alere says feds wont take action in billing probe American City Business Journals
Jun-14-17 12:10PM  Top Stock Reports for United Technologies, Abbott, Delta Air & Others Zacks
Jun-12-17 09:39AM  Abbott Laboratories Saw a Recent Breakout TheStreet.com
Jun-09-17 04:15PM  AbbVie must pay $15 mln in Depakote birth-defect trial: jury Reuters
03:56PM  Abbott Labs Declares Quarterly Dividend GuruFocus.com
03:35PM  FDA Approval Boosts Baxters Generic Injectable Business Market Realist
12:41PM  AbbVie Ordered by Jury to Pay $15 Million to Depakote Victim Bloomberg
10:15AM  Abbott Declares 374th Consecutive Quarterly Dividend PR Newswire
Jun-07-17 09:30AM  Birmingham health exec enters governor's race American City Business Journals
Jun-06-17 09:31AM  Biotech Movers: Albany Molecular Shares Soar on Sale to PE Firms TheStreet.com
Jun-05-17 10:35AM  Abbott Laboratories at 52-Week High on Product Line, Buyouts Zacks
Jun-03-17 02:04PM  3 Best Dividend Stocks in the Medical Device Industry Motley Fool
Jun-02-17 09:30AM  The Zacks Analyst Blog Highlights: McCormick & Company, S&P Global, Sherwin-Williams, 3M and Abbott Laboratories Zacks
May-30-17 09:30AM  The Zacks Analyst Blog Highlights: Visa, General Electric, GlaxoSmithKline, Morgan Stanley and Abbott Laboratories Zacks
07:36AM  Abbott Is Expected to Report a Modest Rise in Net Profit Margins Market Realist
May-29-17 10:36AM  Why Abbott Is Expected to Report Robust Revenue Growth in 2017 Market Realist
09:06AM  Abbott Laboratories Still Dominates the Medical Device Segment Market Realist
08:10AM  Abbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : May 29, 2017 Capital Cube
07:36AM  Global Markets May Drive Established Pharmaceuticals Growth Market Realist
May-26-17 12:44PM  Top Analyst Reports for Visa, GE, GlaxoSmithKline & Others Zacks
10:37AM  Abbott Continues to Expand Its Diagnostics Portfolio in 2017 Market Realist
09:07AM  Emerging Markets Drive Abbotts Nutritional Business Growth Market Realist
07:37AM  St. Jude Medical May Establish ABT as a Key Medical Device Player Market Realist
May-25-17 05:35PM  How Will Abbott Laboratories Benefit from Its Alere Acquisition? Market Realist
03:54PM  Analysts Recommendations for Abbott Laboratories in May 2017 Market Realist
02:36PM  Is Medical Technology Driving the US Healthcare Industry? Market Realist
09:30AM  The Zacks Analyst Blog Highlights: Alphabet, Morgan Stanley, Abbott, Waste Management, General Mills and Raytheon Zacks
May-24-17 06:27PM  FDA: Controller for heart pump recalled over deaths Associated Press
06:27PM  FDA: Controller for heart pump recalled over deaths Associated Press
01:48PM  Analyst Reports for Alphabet, Morgan Stanley, Abbott & Others Zacks
07:00AM  Wide-Moat Roche Is Undervalued Morningstar
May-23-17 03:57PM  Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna GuruFocus.com
May-22-17 07:10AM  Abbott Labs (ABT) Down 2.3% Since Earnings Report: Can It Rebound? Zacks
May-19-17 09:50AM  Give Your Grad The Gift Of A Million-Dollar Dividend Stock Portfolio For A Few Hundred Bucks Forbes
May-17-17 09:30AM  The Zacks Analyst Blog Highlights: General Dynamics, EOG Resources, Abbott, Northrop Grumman and Symantec Zacks
09:17AM  Abbott Lab Well Poised on Strong EPD, St. Jude Integration Zacks
May-16-17 01:31PM  Analyst Reports for Abbott, EOG, General Dynamics & Others Zacks
11:32AM  Goldman Starts Abbott Laboratories at 'Neutral' TheStreet.com
May-12-17 04:36PM  Retired baseball player DeCinces found guilty of insider trading Reuters
May-09-17 09:00AM  Abbott Announces CE Mark for TactiCath Contact Force Ablation Catheter, Sensor Enabled PR Newswire
07:30AM  Cramer: These Sectors Look Bullish (Part III) TheStreet.com
May-08-17 05:36PM  Abbott Laboratories Value Analysis (NYSE:ABT) : May 8, 2017 Capital Cube
09:00AM  Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor PR Newswire
06:00AM  Abbott Announces National Reimbursement for FreeStyle® Libre in France, Providing Access to Revolutionary Technology for People with Diabetes PR Newswire
May-05-17 08:15AM  Abbott Laboratories breached its 50 day moving average in a Bullish Manner : ABT-US : May 5, 2017 Capital Cube
07:20AM  S&P Dividend Aristocrats: Which Stocks Make the List? Motley Fool
May-01-17 03:15PM  Alere, set to be acquired by Abbott, dealt setback in Medicare case American City Business Journals
Apr-28-17 08:51AM  Global med-tech firms, India locked in tussle after stent price sting Reuters
Apr-26-17 08:00AM  Abbott Introduces Science-Based Nutrition Drinks to Help Patients Have a Better Recovery from Surgery PR Newswire
Apr-25-17 03:59PM  Global Market For Medical Implants To Hit Nearly $27 Billion In 5 Years Benzinga
Apr-24-17 06:48PM  Cramer's lightning round: Nobody ever made money betting against this CEO CNBC
07:36AM  A Look at Johnson & Johnsons Major Developments in 1Q17 Market Realist
Apr-21-17 02:33PM  AB's 4-star stock picks CNBC Videos
09:30AM  The Zacks Analyst Blog Highlights: IBM, Abbott, Dow Chemical, Delta Air Lines and Exelon Zacks
08:35AM  Edited Transcript of ABT earnings conference call or presentation 19-Apr-17 1:00pm GMT Thomson Reuters StreetEvents
Apr-20-17 02:58PM  Q1 Scorecard & Stock Research Reports for IBM, Abbott and others Zacks
02:43PM  LPC: US healthcare lending rouses from policy-induced sedation Reuters
11:51AM  [$$] GTCR Forms Medical-Device Platform The Wall Street Journal
11:02AM  Company News for April 20, 2017 Zacks
Apr-19-17 08:10PM  Abbott CEO Upbeat Despite Ongoing Merger Headaches TheStreet.com
05:15PM  Merger Challenges, FDA Concerns Dampen Abbott Gains Despite Strong First Quarter TheStreet.com
04:24PM  Abbott Delivers Street-Crushing Q1 Following St. Jude Buy Investor's Business Daily
12:22PM  Abbott sees Alere as challenging 'fixer-upper' after revised deal Reuters
10:48AM  Story Stocks from Briefing.com Briefing.com
10:44AM  Abbott (ABT) Tops Q1 Earnings on Strong EPD, Medical Device Zacks
10:03AM  Stocks to Watch: Morgan Stanley, IBM, Abbott Labs The Wall Street Journal
09:27AM  Abbott sales, profit propped up by St. Jude acquisition Reuters
09:20AM  Abbott Laboratories (ABT) Tops Q1 Earnings & Sales Estimates Zacks
09:13AM  Abbott's profit rises 33 percent after St. Jude Medical deal Associated Press
07:59AM  Abbott shares rise 2.5% after first-quarter earnings, profit beats MarketWatch
07:58AM  Abbott posts 29.7 pct rise in quarterly sales Reuters
07:51AM  Abbott Labs beats Street on top and bottom line CNBC Videos
07:45AM  Abbott Reports First-Quarter 2017 Results PR Newswire
07:06AM  Market Recon: The Banks Trade Will Become a Yield Curve Watch TheStreet.com
Apr-18-17 01:55PM  5 Stocks with Great Earnings Charts Zacks
10:52AM  Company News for April 18, 2017 Zacks
Apr-17-17 11:59PM  [$$] Cyber Insurance Becomes a Must for More Manufacturers The Wall Street Journal
11:52PM  Asian stock markets mixed as North Korea tensions lessen Associated Press
04:37PM  Why Straight Path Communications, Alere, and MoneyGram International Jumped Today Motley Fool
04:17PM  Will Abbott, Alere Make It To Altar In New Merger Deal? Investor's Business Daily
02:05PM  Abbott Laboratories 1Q17 Earnings: What to Expect Market Realist
02:05PM  Abbott & Alere: Back Together Again Barrons.com
01:26PM  Carson Block Says Theres Temptation to Short Abbott Bloomberg Video
01:21PM  Alere Inc. Shares Surge After Renewed Commitment From Abbott Laboratories Motley Fool
12:35PM  Analyzing Abbott Laboratories 1Q17 Revenue Estimates Market Realist
11:16AM  Company News for April 17, 2017 Zacks
Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Watkin JaredSenior Vice PresidentJun 15Sale47.9755226,48246,538Jun 16 05:02 PM
Fussell Stephen RExecutive Vice PresidentJun 08Option Exercise25.56196,5505,023,939378,688Jun 09 05:04 PM
Fussell Stephen RExecutive Vice PresidentJun 08Sale46.00196,5509,041,360182,138Jun 09 05:04 PM
BIRD ROGERSenior Vice PresidentApr 27Sale43.825,600245,39351,313Apr 28 05:28 PM
MANNING JOSEPH JSenior Vice PresidentApr 26Option Exercise26.703,20085,43126,224Apr 28 05:27 PM
MANNING JOSEPH JSenior Vice PresidentApr 26Sale43.954,200184,59922,024Apr 28 05:27 PM
Contreras JaimeSenior Vice PresidentMar 31Sale44.6476734,2402,410Apr 04 05:02 PM
YOOR BRIAN BExecutive Vice President & CFOMar 01Sale45.391,72878,43463,425Mar 02 05:19 PM
NATH DEEPAK S.Senior Vice PresidentMar 01Sale45.391,60172,66951,430Mar 02 05:17 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentMar 01Sale45.392,06693,77672,112Mar 02 05:16 PM
Watkin JaredSenior Vice PresidentMar 01Sale45.3997044,02848,511Mar 02 05:12 PM
Warmuth Michael JExecutive Vice PresidentMar 01Sale45.393,851174,79756,508Mar 02 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 28Sale44.9674433,45323,024Mar 02 05:18 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 28Sale45.0185738,569100,879Mar 02 05:15 PM
BIRD ROGERSenior Vice PresidentFeb 28Sale45.021,60172,06956,913Mar 02 05:11 PM
Mason Heather LExecutive Vice PresidentFeb 28Sale45.011,91286,06859,677Mar 02 05:06 PM
Contreras JaimeSenior Vice PresidentFeb 28Sale45.0113,155592,15745,733Mar 02 05:05 PM
Funck Robert EVice President, ControllerFeb 23Option Exercise26.7025,500680,781117,579Feb 24 05:28 PM
Funck Robert EVice President, ControllerFeb 23Sale45.5025,5001,160,25092,079Feb 24 05:28 PM
BIRD ROGERSenior Vice PresidentFeb 22Option Exercise26.6212,903343,53975,767Feb 22 05:59 PM
BIRD ROGERSenior Vice PresidentFeb 22Sale45.0212,903580,93862,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Option Exercise26.7093,4002,493,528382,197Feb 22 05:57 PM
MANNING JOSEPH JSenior Vice PresidentFeb 21Sale44.981466,56720,146Feb 22 06:18 PM
BIRD ROGERSenior Vice PresidentFeb 21Sale44.9431914,33562,864Feb 22 05:59 PM
CAPEK JOHN MExecutive Vice PresidentFeb 21Sale45.0093,4004,203,000288,797Feb 22 05:57 PM
Watkin JaredSenior Vice PresidentFeb 21Sale44.9855524,96551,977Feb 22 05:57 PM
NATH DEEPAK S.Senior Vice PresidentFeb 21Sale44.9831914,34957,333Feb 22 05:34 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Option Exercise25.253,40085,83791,857Feb 15 05:04 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 13Sale43.003,400146,20088,457Feb 15 05:04 PM
MANNING JOSEPH JSenior Vice PresidentFeb 03Option Exercise25.253007,57420,792Feb 07 05:02 PM
Mason Heather LExecutive Vice PresidentJan 31Option Exercise25.2535,700901,286100,189Feb 02 05:31 PM
Fussell Stephen RExecutive Vice PresidentJan 31Buy40.7712,200497,394167,167Feb 02 05:32 PM
Mason Heather LExecutive Vice PresidentJan 31Sale40.7735,7001,455,48964,489Feb 02 05:31 PM
Blaser Brian JExecutive Vice PresidentDec 20Buy38.4515,580599,120145,062Dec 21 02:19 PM
Ford Robert BExecutive Vice PresidentDec 14Buy39.0912,775499,34569,542Dec 16 05:07 PM
CAPEK JOHN MExecutive Vice PresidentNov 16Option Exercise24.3822,000536,386274,524Nov 18 05:02 PM
WHITE MILES DChairman and CEONov 10Buy40.6758,2632,369,4483,111,967Nov 14 10:04 AM
WHITE MILES DChairman and CEONov 10Buy40.5389,5783,630,2943,004,943Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.6548,7611,982,0793,053,704Nov 14 10:03 AM
WHITE MILES DChairman and CEONov 10Buy40.5451,8922,103,4552,793,909Nov 14 10:02 AM
WHITE MILES DChairman and CEONov 10Buy40.45121,4564,912,7412,915,365Nov 14 10:02 AM
Blount Sally E.DirectorNov 01Buy39.245,100200,12420,143Nov 02 05:12 PM
Salvadori Daniel Gesua SiveSenior Vice PresidentSep 26Sale41.7181533,99458,976Sep 28 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 29Option Exercise25.2556,0001,413,782438,682Jul 29 05:04 PM
Fussell Stephen RExecutive Vice PresidentJul 28Option Exercise25.2541,5001,047,713196,467Jul 29 05:03 PM
Fussell Stephen RExecutive Vice PresidentJul 28Sale45.0041,5001,867,640154,967Jul 29 05:03 PM
Warmuth Michael JExecutive Vice PresidentJul 26Option Exercise25.2526,800676,59581,811Jul 27 04:43 PM
Warmuth Michael JExecutive Vice PresidentJul 26Sale43.4926,8001,165,45755,011Jul 27 04:43 PM
WHITE MILES DChairman and CEOJul 25Option Exercise25.25550,00013,885,3552,010,517Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Option Exercise25.2526,800676,595111,819Jul 27 04:44 PM
WHITE MILES DChairman and CEOJul 25Buy43.3417,933777,1622,742,017Jul 27 04:31 PM
WHITE MILES DChairman and CEOJul 25Buy43.26176,8047,648,8232,724,084Jul 27 04:30 PM
WHITE MILES DChairman and CEOJul 25Buy43.19181,2637,828,6282,434,327Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.34112,9534,895,2172,547,280Jul 27 04:29 PM
WHITE MILES DChairman and CEOJul 25Buy43.18242,54710,472,9392,253,064Jul 27 04:27 PM
Funck Robert EVice President, ControllerJul 25Sale43.0826,8001,154,54485,019Jul 27 04:44 PM